Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Preferred Stock Liabilities (2018 - 2019)

Historic Preferred Stock Liabilities for TransMedics (TMDX) over the last 2 years, with Q1 2019 value amounting to $186.5 million.

  • TransMedics' Preferred Stock Liabilities changed N/A to $186.5 million in Q1 2019 from the same period last year, while for Mar 2019 it was $186.5 million, marking a year-over-year change of. This contributed to the annual value of $186.5 million for FY2018, which is N/A changed from last year.
  • As of Q1 2019, TransMedics' Preferred Stock Liabilities stood at $186.5 million.
  • In the past 5 years, TransMedics' Preferred Stock Liabilities ranged from a high of $186.5 million in Q4 2018 and a low of $186.5 million during Q4 2018